PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number- dependent manner

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 2099-2106

  Bos, Monique ^a   Mendelsohn, John ^a   Kim, Young Mee ^a   Albanell, Joan ^b   Fry, David W ^b,c   Baselga, Jose ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLONIC NEOPLASMS; ENZYME INHIBITORS; FEMALE; GENES, ERBB-2; HUMANS; MALE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; QUINAZOLINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0030697807     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Carpenter, G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem., 56: 881-914, 1987.
2. Carpenter, G., and Cohen, S. Epidermal growth factor. J. Biol. Chem., 265: 7709-7712, 1990.
3. Di Marco, E., Pierce, J. H., Fleming, T. P., Kraus, M. H., Molloy, C. J., Aaronson, S. A., and Di Fiore, P. P. Autocrine interaction between TGF α and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene, 4: 831-838, 1989.
4. Derynck, R. The physiology of transforming growth factor-α. Adv. Cancer Res., 58: 27-52, 1992.
5. Sporn, M. B., and Todaro, G. J. Autocrine growth factors and cancer. Nature (Lond.), 313: 747-751, 1985.
6. Baselga, J., and Mendelsohn, J. Receptor blockade with monoclonal antibodies as anti-cancer therapy. Pharmacol. Ther., 64: 127-154, 1994.
7. Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., and Mendelsohn, J. Growth stimulation of A431 cells by EGF: Identification of high affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. Natl. Acad. Sci. USA, 80: 1337-1341, 1983.
8. Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., McLeod, C., and Mendelsohn, J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J. Biol. Chem., 259: 7755-7760, 1984.
9. Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J., Polikoff, J., and Sato, G. H. Biological effect in vitro of monoclonal antibodies to human EGF receptors. Mol. Biol. Med., 1: 511-529, 1983.
10. Levitzki, A., and Gazit, A. Tyrosine kinase inhibition. An approach to drug development. Science (Washington DC), 267: 1782-1787, 1995.
11. Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., and Bridges, A. J. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science (Washington DC), 265: 1093-1095, 1994.
12. Goldstein, N. I., Prewett, M., Zuklys, K., Rockwell, P., and Mendelsohn, J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res., 1: 1311-1318, 1995.
13. Untawale, S., Zorbas, M. A., Hodgson, C. P., Coffey, R. J., Gallick, G. E., North, S. M., Wildrick, D. M., Olive, M., Blick, M., Yeoman, L. C., and Boman, B. M. Transforming growth factor-α production and autoinduction in a colorectal carcinoma cell line (Difi) with amplified epidermal growth factor receptor gene. Cancer Res., 53: 1630-1636, 1993.
14. Haigler, H., Ash, J. F., Singer, S. J., and Cohen, S. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A431. Proc. Natl. Acad. Sci. USA, 75: 3317-3321, 1978.
15. Filmus, J., Pollak, M. N., Gailleau, R., and Buick, R. N. MDA-468, a human breast carcinoma cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 12: 889-905, 1985.
16. MacDonald, A., and Habib, F. K. Divergent responses to epidermal growth factor receptor in hormone sensitive and insensitive human prostate cancer cell lines. Br. J. Cancer, 65: 177-182, 1992.
17. Arteaga, C. L., Hurd, S. D., Dugger, T. G., Winnier, A. R., and Robertson, J. C. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth α-Pseudomonas exotoxon 40 fusion protein. Cancer Res., 54: 4703-4709, 1994.
18. Davidson, N. E., Gelmann, E. P., Lippman, M. E., and Dickson, R. B. Epidermal growth factor gene expression in estrogen-positive and negative human breast cancer cell lines. Mol. Endocrinol., 1: 216-223, 1987.
19. Brown, C. L., Rubin, M., Masui, H., and Mendelsohn, J. Growth inhibition by anti-EGF receptor monoclonal antibodies in squamous cervical carcinoma cells expressing TGF-α. Proc. Am. Assoc. Cancer Res., 35: 2270, 1994.
20. HER2 monoclonal antibodies. Cancer Immunol. Immunother., 37: 255-263, 1993.
21. Barnes, D. W. Epidermal growth factor inhibits growth of A431 epidermoid carcinoma cells in serum-free cell culture. J. Cell Biol., 93: 1-4, 1982.
22. Bos, M., Mendelsohn, J., Bowden, D., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., D'Andrea, G., Waksal, H., Norton, L., and Baselga, J. Phase I studies of anti-epidermal growth factor receptor (EGFR) chimeric monoclonal antibody C225 in patients with EGFR overexpressing tumors. Proc. Am. Soc. Clin. Oncol., 15: 443, 1996.
23. Modjtahedi, H., Styles, J. M., and Dean, C. J. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468. Br. J. Cancer, 67: 247-253, 1993.
24. Baselga, J., Mendelsohn, J., Kim, Y. M., and Pandiella, A. Autocrine regulation of membrane transforming growth factor a cleavage. J. Biol. Chem., 271: 3279-3284, 1996.
25. Kawamoto, T., Mendelsohn, J., Le, A., Sato, G. H., Lazar, C. S., and Gill, G. N. Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J. Biol. Chem., 259: 7761-7766, 1984.
26. McLeod, H. L., Brunton, V. G., Eckardt, N., Lear, M. J., Robins, D. J., Workman, P., and Graham, M. A. In vivo pharmacology and anti-tumor evaluation of the tyrphostin tyrosine kinase inhibitor RG13022. Br. J. Cancer, 74: 1714-1718, 1996.
27. Fan, Z., Lu, Y., Wu, X., and Mendelsohn, J. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J. Biol. Chem., 269: 27595-27602, 1994.